Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingResults3 Nov 2026

Qualitek Labs Ltd

Qualitek Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Unaudited Financial Result (Standalone and Consolidated) of the Company for half year ended September 30, 2026 along with Limited Review Report of the Statutory Auditor

Qualitek Labs Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve Unaudited Financial Result for half year ended September 30, 2026.

Read more →📎 1 attachment
BSEResultResults3 Nov 2026

Mangal Compusolution Ltd

Please find enclosed herewith Unaudited Financials Reults for the half year ended 30th September, 2026

Mangal Compusolution Ltd has announced its unaudited financial results for the half year ended 30th September, 2026. The company's revenue from operations was ₹1,395.78 crore, with a total income of ₹1,675.11 crore. The trading window for dealing in the company's securities will open after 48 hours of the results being made public.

Read more →📎 1 attachment
BSEBoard MeetingResults3 Nov 2026

Lee & Nee Softwares Exports Ltd

Lee & Nee Softwares Exports Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Lee & Nee Softwares Exports Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve The Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended ....

Lee & Nee Softwares Exports Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended.

Read more →📎 1 attachment
BSEResultResults3 Nov 2026

Ishita Drugs & Industries Ltd

Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026 alongwith limited review report issued by the statutory auditors of the Company.

Ishita Drugs & Industries Ltd has announced its unaudited financial results for the quarter and half year ended 30th September, 2026, along with a limited review report from its statutory auditors. The company has also discussed its upgradation project for its manufacturing facility to comply with Revised Schedule M.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults3 Nov 2026

Global Health Limited

Investor Presentation

Global Health Limited (Medanta) has announced its Q2 and H1 FY2027 results, showing a 34% year-over-year revenue growth, driven by a 29.5% increase in in-patient volumes and a 37.9% increase in out-patient volumes. The company added 74 new beds across its network, with a total census bed capacity of 3,115 in Q2FY27. Operating EBITDA grew 60.2% y-o-y to INR 3,701 million, with improved margins of 25.2% in Q2 FY27 compared to 21.0% in Q2FY26.

Read more →📎 1 attachment
BSEResultResults3 Nov 2026

SPA Capital Services Ltd

Unaudited Financial Results along with Limited Review Report for Quarter and Half Year September ended 2026.

SPA Capital Services Ltd has announced unaudited financial results for the quarter and half year ended September 30, 2026, along with a limited review report by the statutory auditors. The results show that the company has taken various loans, which were outstanding as on September 30, 2026, and has not provided interest on some of these loans, resulting in a departure from the Accrual basis of accounting. Additionally, the company has given loans to various parties, which were outstanding as on September 30, 2026, and has not charged any interest on such loans, leading to a potential overstatement of profits and understatement of provisions for loss assets.

Read more →📎 1 attachment
BSEBoard MeetingResults3 Nov 2026

Ratnakar Securities Ltd

The Board considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2026 and taken on record the Limited Review Report thereon.

Ratnakar Securities Ltd has announced its un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, and has taken on record the Limited Review Report.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults3 Nov 2026

Gandhi Special Tubes Limited

Outcome of Board Meeting

Gandhi Special Tubes Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors in their meeting held on November 3, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults3 Nov 2026

Genpharmasec Ltd

Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026.

Genpharmasec Ltd has announced the outcome of its Board Meeting held on November 3, 2026. The Board has approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with a limited review report from the statutory auditor. Additionally, the Board has approved the disinvestment of its entire equity stake in Clinigenome India Private Limited, a wholly-owned subsidiary, and the resignation of Mr. Hardik Makwana as Company Secretary and Compliance Officer.

Read more →📎 1 attachment
NSEUpdatesResults3 Nov 2026

Gammon India Limited

Updates

Gammon India Limited has informed the Exchange regarding the Board Meeting to be held on 6th November, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Statements for the quarter ended 30th September, 2026.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults3 Nov 2026

Global Health Limited

Press Release

Global Health Limited, the parent company of Medanta, has reported robust quarterly performance driven by bed additions and strong growth in patient volumes. Revenue from operations was INR 14,690 million in Q2FY27, up 33.6% y-o-y, with operating EBITDA growing 60.2% y-o-y to INR 3,701 million and improved margins of 25.2%. The company added 74 new beds across the network, with 25 beds added at Lucknow and 49 beds in Noida, and witnessed robust volume growth with in-patient count growing by 29.5% and out-patient count growing by 37.9% y-o-y.

Read more →📎 1 attachment
BSEResultResults3 Nov 2026

Subros Ltd

Board of Director approved Unaudited Financial results for the quarter and half year ended 30th September, 2026 in its meeting held on 3rd November, 2026.

Subros Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with the Board of Directors approving the results in its meeting held on November 3, 2026. The results include revenue from operations of Rs. 1,19,890 lakhs for the quarter and Rs. 2,23,101 lakhs for the half year.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults3 Nov 2026

Awfis Space Solutions Limited

Outcome of Board Meeting

Awfis Space Solutions Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, and announced the resignation of Ms. Shweta Gupta as Company Secretary & Compliance Officer, with Ms. Juhi Garg appointed as her replacement. The company also extended the timeline for the completion of the transfer of its Design & Build Business to Awfis Transform Private Limited.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults3 Nov 2026

ACC Limited

Analysts/Institutional Investor Meet/Con. Call Updates

ACC Limited's subsidiary Ambuja Cements Limited has reported a resilient second quarter performance for FY27, with a focus on quality growth despite elevated fuel and logistics costs. The company has 14 expansion projects to add approximately 30 million tons of cement and 10.3 million tons of clinker capacity.

Read more →📎 1 attachment
← PreviousPage 912 of 4497Next →